Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

ClinicalTrials.gov ID: NCT07752979

Public ClinicalTrials.gov record NCT07752979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Dose-Finding Study to Assess the Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Obesity is a condition where a person has excessive body fat, defined by a body mass index (BMI) of 30 kg/m2 or higher. The goal of this study is to evaluate the effect of various doses of ABBV-295 compared to placebo on reducing body weight at Week 32 in participants with obesity or overweight with weight-related comorbidities. ABBV-295 is an investigational long-acting amylin analog being developed for chronic weight management. Participants are placed into multiple treatment groups with different dosing paradigms of ABBV-295 or placebo. Participants will not know which treatment they are receiving, and there is a chance of being assigned to placebo. Adults with obesity or overweight (as defined by BMI) with weight-related comorbidities will be enrolled. Approximately 360 participants will be enrolled in the study at approximately 70 sites in the United States and Puerto Rico. Participants will receive subcutaneous (SC) injections of ABBV-295 solution for injection or matching placebo administered via pre-filled syringes for 52 weeks during the Double-Blind Period. There may be higher treatment burden for participants in this trial compared to their standard of care due to study procedures. Participants will attend regular visits during the study at a hospital or clinic. The effects of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Study identification

NCT ID
NCT07752979
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
360 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 4, 2026 (Actual)
Primary completion
Mar 2028 (Estimated)
Completion
Mar 2028 (Estimated)
Last update posted
Oct 20, 2026

2026 – 2028

United States locations

U.S. sites
59
U.S. states
20
U.S. cities
56
Facility City State ZIP Site status
Cahaba Research - Pelham /ID# 282381 Pelham Alabama 35124 Recruiting
Headlands Research - Scottsdale /ID# 282571 Scottsdale Arizona 85260 Recruiting
Arizona Clinical Trials /ID# 282372 Tucson Arizona 85711 Recruiting
John Muir Health - Concord /ID# 282469 Concord California 94520 Recruiting
NorCal Medical Research /ID# 283117 Greenbrae California 94904 Recruiting
Velocity Clinical Research - Huntington Park /ID# 282987 Huntington Park California 90255 Recruiting
Los Angeles Institute for Metabolic Research /ID# 282059 Los Angeles California 90015 Recruiting
Peninsula Research Associates /ID# 282158 Rolling Hills Estates California 90274 Recruiting
Southern California Dermatology /ID# 282011 Santa Ana California 92701 Recruiting
Encompass Clinical Research /ID# 282483 Spring Valley California 91978 Recruiting
University Clinical Investigators /ID# 282132 Tustin California 92780 Recruiting
Diablo Clinical Research /ID# 282530 Walnut Creek California 94598 Recruiting
Innovative Research of West Florida /ID# 281963 Clearwater Florida 33756 Recruiting
Northeast Research Institute (NERI) /ID# 282015 Fleming Island Florida 32003 Recruiting
Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740 Jacksonville Florida 32216 Recruiting
Altus Clinical Research - Lake Worth - South Congress Avenue /ID# 281979 Lake Worth Florida 33461 Recruiting
South Florida Wellness & Clinic /ID# 282022 Margate Florida 33063 Recruiting
South Broward Research /ID# 282125 Miramar Florida 33027 Recruiting
Suncoast Clinical Research Pasco County /ID# 282412 New Port Richey Florida 34652 Recruiting
Charter Research - Winter Park /ID# 281968 Orlando Florida 32803-1839 Recruiting
Florida Institute For Clinical Research /ID# 282739 Orlando Florida 32825 Recruiting
Progressive Medical Research /ID# 282838 Port Orange Florida 32127 Recruiting
Charter Research - The Villages /ID# 282376 The Villages Florida 32162 Recruiting
Metabolic Research Institute /ID# 282350 West Palm Beach Florida 33401 Recruiting
Encore Medical Research - Weston /ID# 282044 Weston Florida 33331 Recruiting
Endocrine Research Solutions /ID# 282020 Roswell Georgia 30076 Recruiting
Elite Clinical Trials - Blackfoot /ID# 282042 Blackfoot Idaho 83221 Recruiting
Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378 Chicago Illinois 60640 Recruiting
L-MARC Research Center /ID# 282008 Louisville Kentucky 40213 Recruiting
Prime Health and Wellness /ID# 282254 Fayette Mississippi 39069 Recruiting
Studymetrix Research /ID# 282163 City of Saint Peters Missouri 63303 Recruiting
Mercury Street Medical /ID# 282016 Butte Montana 59701-1652 Recruiting
Vector Clinical Trials /ID# 282265 Las Vegas Nevada 89128 Recruiting
Rochester Clinical Research /ID# 282484 Rochester New York 14609 Recruiting
Medication Management /ID# 281965 Greensboro North Carolina 27401 Recruiting
Monroe Biomedical Research /ID# 282009 Monroe North Carolina 28112 Recruiting
Centricity Research - Morehead city /ID# 283264 Morehead City North Carolina 28557 Recruiting
Lucas Research - New Bern /ID# 282747 New Bern North Carolina 28562 Recruiting
Accellacare - Tradd Court - Wilmington /ID# 282200 Wilmington North Carolina 28401 Recruiting
Lillestol Research LLC /ID# 281978 Fargo North Dakota 58104 Recruiting
CTI Clinical Research Center /ID# 282043 Cincinnati Ohio 45212-3784 Recruiting
Holston Medical Group - Bristol /ID# 282045 Bristol Tennessee 37620 Recruiting
New Phase Research & Development /ID# 282131 Knoxville Tennessee 37909 Recruiting
Summit Medical Group- Halls Family Physicians /ID# 282435 Knoxville Tennessee 37938 Recruiting
Clinical Research Associates - Nashville /ID# 282161 Nashville Tennessee 37203 Recruiting
Amarillo Medical Specialists /ID# 282380 Amarillo Texas 79124 Recruiting
Elligo Clinical Research Center /ID# 282166 Austin Texas 78704 Recruiting
JCCT - Juno Bellaire /ID# 282263 Bellaire Texas 77401 Recruiting
Velocity Clinical Research - Dallas /ID# 282734 Dallas Texas 75230 Recruiting
Juno Research /ID# 282413 Houston Texas 77040 Recruiting
PlanIt Research /ID# 282204 Houston Texas 77079-2204 Recruiting
Dcol Center For Clinical Research /ID# 281961 Longview Texas 75605 Recruiting
Southern Endocrinology Associates /ID# 282558 Mesquite Texas 75149 Recruiting
Texas Diabetes and Endocrinology /ID# 282291 Round Rock Texas 78681 Recruiting
Washington Center For Weight Management And Research /ID# 282047 Arlington Virginia 22206 Recruiting
Sovah Health - Danville /ID# 282876 Danville Virginia 24541 Recruiting
Health Research Of Hampton Roads /ID# 282014 Newport News Virginia 23606 Recruiting
National Clinical Research /ID# 282007 Richmond Virginia 23294 Recruiting
Rainier Clinical Research /ID# 282157 Renton Washington 98055 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07752979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07752979 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →